CG
COLL icon

Cutler Group’s Collegium Pharmaceutical COLL Stock Holding History

Cutler Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,100
Closed -$3K – 4438
2020
Q1 		$3K Buy
+2,100
New +$43.3K ﹤0.01% 3292
2019
Q3 		– Sell
-800
Closed -$1K – 4150
2019
Q2 		$1K Buy
+800
New +$10.7K ﹤0.01% 3807
2018
Q4 		– Sell
-1,900
Closed -$1K – 4009
2018
Q3 		$1K Buy
+1,900
New +$33.7K ﹤0.01% 3727
2018
Q1 		– Sell
-2,900
Closed -$8K – 4545
2017
Q4 		$8K Buy
+2,900
New +$41.5K ﹤0.01% 3284
2017
Q2 		– Sell
-4,000
Closed -$6K – 6424
2017
Q1 		$6K Buy
+4,000
New +$59.5K ﹤0.01% 4517
2016
Q3 		– Sell
-900
Closed -$5K – 6717
2016
Q2 		$5K Buy
+900
New +$14.9K ﹤0.01% 4895

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Cutler Group's COLL Position: Q1 2019 in Review

Cutler Group sold out of Collegium Pharmaceutical (COLL) in Q1 2019, closing a stake of 1,500 shares — an estimated $25K sold.

Cutler Group first reported a position in COLL in Q4 2016 and held it in 9 quarters. The position peaked at $168K in Q1 2018. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

  • Cutler Group reported no remaining Collegium Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 1,500 Collegium Pharmaceutical shares in Q1 2019, an estimated $25K.
  • Cutler Group first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 9 quarters.
  • Cutler Group's Collegium Pharmaceutical position peaked at $168K in Q1 2018.
  • 145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.